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Chloroform Induction of Ornithine
Decarboxylase Activity in Rats
by Russell E. Savage, Jr.,* Carol Westrich,*
Charles Guion* and Michael A. Pereira*
Chloroform is a drinking water contaminant that has been demonstrated to be carcinogenic to
mice and rats resulting in an increased incidence of liver and kidney tumors, respectively. The
mechanism ofchloroform carcinogenicity might be by tumor initiation and/or promotion. Since
inductionofornithinedecarboxylase (ODC) activity has been proposed as amolecularmarkerfor
tumor promoters, we have investigated the effect of chloroform on ODC activity in rats.
Chloroform induced adose-dependent increase ofhepatic ODC with an apparent threshold at 100
mg/kg body weight. Female rats were two to four times more susceptible to chloroform. Upon
daily dosing of chloroform for 7 days the liver became less susceptible, with the last dose of
chloroform resulting in only 10o of the activity observed after a single dose. Nuclear RNA
polymerase I activity was also induced by chloroform. Chloroform, rather than increasing the
activity ofrenal ODC, resulted in a 35% reduction. The induction by chloroform ofhepatic ODC
activity might be associated with regenerative hyperplasia while the renal carcinogenicity of
chloroform could not be demonstrated to be associated with ODC induction.
Introduction
Chloroform has been demonstrated in mice and
rats to increase the incidence of hepatocellular
carcinoma and epithelial tumors of the kidney,
respectively (1). The initiation of carcinogenesis is
believed to involve a somatic mutation; however,
chloroform was nonmutagenic in the Ames Sal-
monella/microsome assay (2), in E. coli K 12 for
basepair substitution (3), and in the 8-azaguanine
locus in Chinese hamster lung fibroblast in cell
culture (4). It also appeared that the amount of
covalent binding of chloroform to rat liver and
kidney DNA was very minimal (5). The negative
evidence for chloroform mutagenicity and the low
level ofDNAinteraction hasresulted in theproposal
that chloroform is not an initiator ofcarcinogenesis
but is rather a tumor promoter.
Chloroform has long been known to be toxic in
the liver and kidney, which vi'e the organs in which
an increased incidence oftumor formation has been
found (1,6,7). Thehepatotoxicity include fattydegen-
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eration, glycogen depletion, vacuolation, swelling
andnecrosis. Theseveretissuedamagethatresulted
in regenerative growth ofthe liver (8) could stimu-
latetheprogression ofpreneoplasticcellstotumors.
This proposed epigenetic stimulation of the neo-
plastic progression is called promotion.
Ornithine decarboxylase (ODC) induction has
been associated with tumor promotion in skin (9)
and liver (10), so that it might be a molecular
marker for tumor promotion. ODC is the first and
rate-limiting enzyme in polyamine biosynthesis (11)
and has a very rapid turnover time of 10-20 min in
liver (12,13). Drugs, hormones, and partial hepat-
oectomy which increased cellular proliferation have
been shown to increase ODC activity (14). In this
communication, we report the effect of chloroform
on ODC activity in rat liver and kidney.
Materials and Methods
Materials
Fischer344 albino rats, weighing 175-200g, were
purchased from Charles River Breeding Labora-
tories (Wilmington, Mass.). Adrenalectomized rats
were also purchased from Charles River. Purina158
Laboratory Chow (Ralston Purina Co., St. Louis,
Mo.) and distilled water were provided ad libitium.
DL-Ornithine 1-14C and uridine triphosphate-'H
were purchased from New England Nuclear (Bos-
ton, Mass.). Chloroform (glass distilled and without
preservative), carbontetrachloride andbenzenewere
obtained from Burdick and Jackson Laboratories
(Muskengun, Mass.), andAroclor-1254waspurchased
from Analab, Inc. (North Haven, Conn.).
Subcellular Fractionation
Animals were sacrificed by decapitation. The liv-
ers or kidneys were removed, rinsed, blotted,
weighed and homogenized in 1.0 volume (1 ml/g
tissue)ofODChomogenizingbuffer(0.1MNaH2PO4,
0.8mM pyridoxal-5-phosphate, 2.0mM EDTA; pH
7.5) at 0°C with a glass homogenizer fitted with a
Teflon pestle. The homogenate was centrifuged at
10,000g for 10 min at 4°C. The supernatant fraction
wasdecantedoffandfurthercentrifuged at 144,000g
for 60 min at 4°C. The 144,000g supernatant frac-
tion was removed with a Pasteur pipet introduced
below the surface to avoid the turbid lipid layer on
top. This cytosol fraction was used as the enzyme
source for the ornithine decarboxylase assay.
Liver nuclei used in the RNA polymerase I assay
were prepared by the isolation procedure devel-
oped by Muramatsu et al. (15) and described by Yu
and Feigelson (16).
Enzyme Assays
All animals for the ornithine decarboxylase assay
were sacrificed between 9 and 10 AM. Cytoplasmic
ODC activity was measured by determination of
the release of 14CO2 from ornithine (1-14C) essen-
tially as described by Bethell and Pegg (17). The
cytoplasmic fraction (100 [lI) was incubated with 900
,ul of ODC incubation medium containing 56mM
NaH2PO4, 3.8mMdithiothreitol, 2.3mMEDTA(pH
6.5) and 1.0 ,uCi of DL-ornithine (1-14C) (51.3 mCi/
mmole). After incubation for 30 min at 37°C the
reaction was stopped bythe addition of0.3ml of5M
H2SO4, and the 4C02released was trapped onfilter
paper discs saturated with 0.25 ml of hyamine
hydroxide. The production of14CO2 was linear with
respect to the amount of enzyme protein added to
each incubation. The discs were removed, placed in
liquid scintillation vials containing 15.0 ml ACS
(Amersham) and 0.41 ml of 0.5N HCl, and the
radioactivity determined in a Beckman LS 8100
liquid scintillation counter (Beckman Instrument
Inc., Palo Alto, Calif.). The background activity,
determined with acid denatured cytosol, was sub-
tracted in each case. Protein was measured by use
of the Bio-Rad protein assay kit (Bio Rad, Rich-
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mond, Calif.). Enzyme activity was expressed as
CO2 evolved/mg protein/30 min incubation.
RNA polymerase I activity was determined by
using purified intact nuclei as the enzyme source as
describedbyRoederand Rutter(18). Isolatednuclei
were incubated in a final volume of 1.0 ml contain-
ing 10 mg pyruvate kinase (400 units/mg protein),
23 ,umole Tris-HCI (pH 7.9), 1.0 ,umole MnCl2, 4.0
,umole KCI, 3.0 ,umole NaF, 2.0 ,umole phosphoenol
pyruvate, 0.8 ,umole 2-mercaptoethanol. 0.3 ,umole
each GTP, CTP, ATP, 0.06 ,umole unlabeled UTP,
0.002 ,umole 3H-UTP (20.3 Ci/,umole), and 50 ,umole
ammonium sulfate and with and without lmM
ot-amanitin (19). Following incubation for 10 min at
30°C, the reaction was terminated by the addition
of 4.0 ml of 10% TCA. The samples were centri-
fuged at 3,000 rpm for 10 min in a Beckman TJ-6
table top centrifuge (Beckman Instrument Inc.,
Palo Alto). The supernatant was discarded and the
pellet washed two times with 3.0 ml of 5% TCA.
The pellet was resuspended in 3.0 ml of 5% TCA
and collected under vacuum onto HA 0.45mM
Millipore filters. The filters were washed with 10 ml
of 5% TCA, followed by 5 ml of 60% ethanol and
allowed to air-dry overnight. The next day they
wereoxidizedinaPackard Model306sample oxidizer
(Packard Instrument Co., Downers Grove, Ill.).
Radioactivity was determined by liquid scintillation
counting and protein measured as described above.
The data were expressed as pica moles of3H-UTP
incorporated/10 min/mg protein.
Results
The effect ofvarious carcinogens and tumor pro-
moters on ornithine decarboxylase (ODC) activity
in male rat liver was determined (Table 1). With
the exception of benzene and saccharin, all of the
compounds tested stimulated ODC. Chlorinated car-
cinogens and tumor promoters such as chloroform,
carbon tetrachloride and the polychlorinated biphe-
nyl, Aroclor-1254, caused the greatest increase in
ODC activity.
Chloroform Time Course
and Dose Response
The time course of chloroform induction of ODC
in male rat liver was determined (Fig. 1). Enhance-
ment was evident as early as 2 hr and slowly
increased until 18 hr, at which time maximum
enhancement of ODC activity occurred. The maxi-
mum enhancement of ODC activity was 43.5-fold
control level and 74 pmole C02/30 min/mg protein.
By 24 hr, the peak enhancement of ODC activity
had decreased by 80%.CHLOROFORM INDUCTION OF ORNITHINE DECARBOXYLASE
Table 1. Effect of suspected tumor promoters on rat hepatic ornithine decarboxylase activity.
Compounda Dose, mg/kg ODC activityb Enhancementc
Aroclor-1254 800 38.1± 4.93d 22.4
Benzene 440 2.6 ± 0.69 1.5
Carbon tetrachloride 800 25.0± 4.30d 14.7
Chloroform 750 74.0± 11.6d 43.5
Methapyrilene 10 9.3 ± 2.96d 5.5
Phenobarbital 100 9.6 ± 1.00d 5.7
Saccharin 1000 2.3 ± 0.31 1.4
Testosterone 300 13.2± 4.± d 7.8
aAnimals were injected intraperitoneally with the compound and sacrificed 18 hr later at 9:00 AM.
bODC activity was determined by measuring the release of14CO2from DL-ornithane (1-14C) and was expressed as pmoleC02/30 min
incubation/mg protein. Results are means from eight animals ± standard error.
cEnhancement of ODC activity compared to the mean of eight saline-treated rats which was 1.7 ± 0.44.
dStatistically greater than the activity in saline-treated rats by the Student t-test at the level ofp < 0.01.
The administration of a daily dose of chloroform
for 7 days resulted in a lower enhancement of ODC
activity compared to a single dose (Fig. 2). After
seven total doses of chloroform, the ODC activity
was only 10% the activity observed after the first
dose. The decreased responsiveness of the liver to
chloroform was even apparent for a second dose of
chloroform administered on the following day.
The dose-response relationship ofODC induction
by chloroform in female and male rats was per-
formed (Fig. 3). Female rats were two to four times
as sensitive to chloroform as male rats. There was
an apparent threshold in male rats for ODC induc-
tion below 100 mg/kg body weight. The ODC activ-
ity increased with dose of chloroform until 750
mg/kg body weight in both female and male rats.
Higher doses of chloroform could not be tested in
females due to a high incidence of lethality.
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FIGURE 1. Time course of chloroform induction of ODC in
male rats. Male rats were injected intraperitoneally with
750mg/kg and sacrificed after various intervals oftime at
9:00 AM. All points represent the mean of a minimum of
eight animals ± S.E.
Renal ODC Activity
The ODC activity ofmale rat kidney was approx-
imately 300-fold the activity in male rat liver (Table
2). The function ofthis high level ofODC activity in
male kidney is unknown; however, after unilateral
nephrectomy, a fourfold increase of ODC activity
occurred 24 hr later in the regenerating kidney
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FIGURE 2. Effects of chronic chloroform treatment on rat
hepatic ornithine decarboxylase activity. Male rats were
injected intraperitoneally with 500 mg/kg CHCl3 daily at
3:00 PM for a period of up to 7 days. Rats were sacrificed
18 hr after their last dose. All points represent the mean of
a minimum of eight animals ± SE.
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FIGURE 3. Dose-response relationship ofchloroform induc-
tion of hepatic ODC. Rats were injected intraperitone-
ally with the appropriate dose ofCHC13 and sacrificed 18
hr later at 9:00 AM. The ODC activity in saline-treated
control female and male rats was 1.7 ± 0.44 and 1.55 +
0.38 enzyme units, respectively. All points represent the
mean of a minimum of eight animals ± SE.
Table 2. Effect ofCHCl3 on rat renal ODC activity.
Dose,
Compound mg/kga Time, hr ODC activityb
Saline 18 482.23 ± 24.23
CHCl3 750 18 317.65 ± 33.55
aAnimals were injected intraperitoneally with either saline or
CHCl3 and the animals sacrificed 18 hr later at 9:00 AM.
bODC activity was expressed as pmole CO2 liberated/30
min/mg protein. Results are means ofeight animals ± standard
errors.
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(20). Chloroform (750 mg/kg body weight), which
resulted in a 43.5-fold enhancement of rat liver
ODC activity (Table 1), caused a 35% reduction of
kidney ODC activity (Table 2).
Hormonal Modulation of Chloroform-
Induced ODC
Adrenalectomy preventedtheincreaseinratliver
ODC activity that resulted from treatment with
barbiturates (Table 3). The extent of chloroform
induction ofODC activity was notstatisticallydimin-
ished by prior adrenalectomy. Therefore, unlike
barbiturates, the enhancement ofrat liver ODC by
chloroform was notdependent onthe adrenalgland.
Pretreatment with propranolol (a beta adrenergic
receptor blocker) or 17-ot-hydroxyprogesterone (a
corticosterone receptor blocker) also did not dimin-
ish the increased level of ODC induced by chloro-
form.
RNA Polymerase I Response to
Chloroform
RNA polymerase I is another enzyme that has
been demonstrated to increase during the hyper-
plastic response in rat liver (14). Chloroform induc-
tion of RNA polymerase I activity was determined
Table 3. Effects of hormonal manipulations on chloroform-induced hepatic ornithine decarboxylase.
Compound Dose, mg/kga Surgeryb ODC activity
Saline 1.7 ±0.44
Saline Adrenalectomy 3.2 ± 0.63
CHCl3 187.5 9.5 + 5.00
CHCl3 187.5 Adrenalectomy 13.5 ± 5.58
CHCl3 375.0 17.7 ± 4.71
CHCl3 375.0 Adrenalectomy 12.6 ± 3.16
CHCl3 750 74.0 ± 11.6
CHCl3 750.0 Adrenalectomy 47.5 ± 19.5
17-Hydroxyprogesterone (HP) 20 1.3 ± 0.36
17-HP + CHCl3e 110.1 ± 13.7
Proproanolol 10 1.7 ± 0.38
Propranolol + CHCl3' 76.9 ± 15.6
Barbital 200 13.1 ± 3.00
Barbital 200 Adrenalectomy 1.1 ± 0.52g
Phenobarbital 100 9.6 ± 1.00
Phenobarbital 100 Adrenalectomy 2.6 ± 0.899
aAnimals were injected intraperitoneally and sacrificed 18 hr later. The 17a-hydroxyprogesterone and propranolol were injected 30
min prior to the chloroform and sacrificed 18 hr later.
bAdrenalectomy was performed by Charles River laboratory. The rats were maintained on saline for their drinking water and used
14 days after surgery.
CODC activity was expressed as pmole C02/30 min incubation/mg protein.
dResults are means of eight animals ± standard errors.
eThe dose of 17a-hydroxyprogesterone was 20 mg/kg body weight and of chloroform 750 mg/kg body weight.
'The dose of propranolol was 10 mg/kg body weight and of chlorofrom 750 mg/kg body weight.
gStatistically decreased from intact animal by the Student t-test at the level of significance ofp < 0.01.CHLOROFORM INDUCTION OF ORNITHINE DECARBOXYLASE 161
Table 4. Effect of CHC13 on rat hepatic RNA polymerase I.
Dose, RNA polymerase I
Compound mg/kga Time, hrb activityc
Saline - 18.5 138.03 ± 16.02d
CHC13 750 18.5 319.40 ± 36.14
aAnimals were injected intraperitoneally with either saline (1
mg/kg body weight) or CHC13. SThe animals were sacrified 18.5 hr after treatment at 9:00
a.m.
CRNA polymerase I activity was calculated in the presence of
lmM a-amanitin and was expressed as pmole UTP incorporat-
ed/10 min/mg protein.
dResults are means of eight animals ± standard errors.
in the presence of lmM a-amanitin (Table 4). The
a-amanitin was used to inhibit RNA polymerase II
and III (Table 4). Chloroform compared to saline
treated rats resulted in a 2.3-fold enhancement of
liver nuclear RNA polymerase I activity.
Discussion
The induction of hepatic ODC has been demon-
strated to be associated with the hyperplastic and
regenerative response to drugs, hormones and par-
tial hepatectomy (21). Chloroform has been demon-
strated to induce a regenerative hyperplasia in rat
liver (8). Chloroform caused a dose-dependent en-
hancement ofhepatic ODC that could be associated
with the regenerative hyperplasia. An apparent
threshold for chloroform induction of ODC activity
was indicated below 100 mg/kg body weight which
might indicate a threshold for regenerative hyper-
plasia. Female rats compared to males exhibited a
2- to 4-fold greater response of ODC induction.
Chloroform also induced hepatic nuclear RNA poly-
merase I, another enzyme that has been associated
with the hyperplastic response in liver (14). The
induction of ODC and hyperplasia has been pro-
posed as molecular markers for tumor promoters
(9).
Tumor promotion appears to require the pro-
longed and repeated administration ofthe promoter
(9). Upon daily administration of chloroform, the
extent ofthe enhancement decreased sothataftera
total ofseven doses, the ODC activity was only 10%
the level after a single dose. This reduction in the
effect of chloroform could have resulted from the
inhibition ofaccumulated putrescine (22). The hyper-
plastic response ofa-hexachlorobenzene inthe liver
as measured by the increase in DNA replication,
was resistant to a second dose (23). The hyperplas-
ticresponse ofchloroform asindicatedbythereduced
enhancement of ODC might also be limited.
The kidney was the target organ of chloroform
carcinogenicity in rats. Kidney ODC activity was
not induced by chloroform but was rather reduced.
The level of ODC activity in kidneys was approxi-
mately 300-fold the hepatic level. Even in presence
of this high control level, unilateral nephrectomy
was capable of inducing ODC in the regenerating
kidney (24). Therefore, the carcinogenicity and pos-
sible tumor promoting activity ofchloroform in rat
kidney would appear not to be associated with the
induction of ODC. In summary, the hepatic regen-
erative hyperplasia induced by chloroform in rats
appeared to be associated with the induction of
ODC while the renal carcinogenicity was not asso-
ciated.
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